We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.
Myllia Biotechnology is a biotech company unlocking the power of CRISPR and singlecell transcriptomics to explore gene function at scale in primary human cells. With a focus on immune cells, Myllia’s VISTA™ platform enables the discovery of high-value drug targets and deep insights into immune cell function. Myllia has built an end-to-end genetic screening platform in primary human cells and cancer cell lines.